Cargando…
Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study
BACKGROUND: Hypovitaminosis D can have a negative prognostic impact in patients with cancer. Vitamin D has a demonstrated role in T-cell-mediated immune activation. We hypothesized that systematic vitamin D repletion could impact clinical outcomes in patients with cancer receiving immune-checkpoint...
Autores principales: | Bersanelli, Melissa, Cortellini, Alessio, Leonetti, Alessandro, Parisi, Alessandro, Tiseo, Marcello, Bordi, Paola, Michiara, Maria, Bui, Simona, Cosenza, Agnese, Ferri, Leonarda, Giudice, Giulia Claire, Testi, Irene, Rapacchi, Elena, Camisa, Roberta, Vincenzi, Bruno, Caruso, Giuseppe, Rauti, Antonio Natale, Arturi, Federica, Tucci, Marco, Santo, Valentina, Ricozzi, Valentina, Burtet, Vanessa, Sgargi, Paolo, Todeschini, Renata, Zustovich, Fable, Stucci, Luigia Stefania, Santini, Daniele, Buti, Sebastiano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576732/ https://www.ncbi.nlm.nih.gov/pubmed/37638980 http://dx.doi.org/10.1007/s00262-023-03522-3 |
Ejemplares similares
-
Clinical impact of COVID-19 in a single-center cohort of a prospective study in cancer patients receiving immunotherapy
por: Bersanelli, Melissa, et al.
Publicado: (2020) -
Profile of atezolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives
por: Facchinetti, Francesco, et al.
Publicado: (2018) -
Monitoring cfDNA in Plasma and in Other Liquid Biopsies of Advanced EGFR Mutated NSCLC Patients: A Pilot Study and a Review of the Literature
por: Verzè, Michela, et al.
Publicado: (2021) -
Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapy
por: Buti, Sebastiano, et al.
Publicado: (2016) -
Clinical use of lenvatinib in combination with everolimus for the treatment of advanced renal cell carcinoma
por: Leonetti, Alessandro, et al.
Publicado: (2017)